Image

MedComm 3.0 Conference

MedComm 3.0 is a cutting-edge event for professionals to learn to streamline the communication of medical information for a global market and to discover the complexities of new communication channels and requirements.

  • MUST ATTEND! Spend TWO-DAYS with renowned Chairperson, Kirk Shepard, Senior Vice President, Global Medical Affairs Oncology, Eisai, as he presents industry challenges and his outlook on the future of medical communications
  • Discover digital breakthroughs and innovative technologies being utilized at GSK with their Group Director of U.S. Medical Information
  • Executive Panel with Merck, Janssen, Alexion Pharmaceuticals Inc. and Adocia, in an interactive session on the evolution of Medical Affairs
  • Authorship protection and promoting practices that mitigate risk
  • Accelerate integration of Health Outcomes Data
Featuring Kirk Shepard - Conference Chair
Senior Vice President, Head of Global Medical Affairs Oncology
Eisai Pharmaceutical Co.

DATE

Oct 24th, 2018 - Oct 26th, 2018


TIME

8:00am - 4:15pm


PRICING

$1,596 (early bird) to $1,996 (door)
REGISTER NOW

VENUE

Wyndham Philadelphia Historic District

Image

H400 Arch St.
Philadelphia, PA 19106
(215) 923-8660
phillydowntownhotel.com

GET DIRECTIONS

Download the Full Agenda

PRE-CONFERENCE MEDICAL WRITING AND COMMUNICATIONS BOOT CAMP

Wednesday, October 24th, 2018
Come prepared for dynamic workshops as you learn with some of the brightest minds in the field!

8:00 AM – 9:00 AM

WORKSHOP REGISTRATION & CONTINENTAL BREAKFAST


9:00 AM – 12:00 PM

MEDICAL COMMUNICATIONS WORKSHOP OVERVIEW

This workshop is designed for individuals with careers in medical communications or professionals looking to enhance their day-to-day job functions. Discuss best practices and the key challenges that face the industry and employees on a daily basis.

Learning Objectives:

  • Explore the different roles and responsibilities for MedComm professionals throughout the drug development lifecycle
  • Discuss best practices, resources and ideas to enhance productivity
  • Uncover the latest trends in pharma affecting MedComm
  • Pinpoint strategies to maximize knowledge transfer for day-to-day job functions
  • Define the value proposition associated with Medical Information for internal and external customers
  • Learn how the regulatory environment influences the efficiency of medical communications

Renu Juneja
Head, Scientific Communications and Training, Oncology Medical Affairs
Janssen Pharmaceuticals


12:00 PM – 1:00 PM

NETWORKING LUNCH


1:00 PM – 4:00 PM

REGULATORY WRITING FOR THE PHARMACEUTICAL, MEDICAL DEVICE AND BIOTECH INDUSTRIES

This regulatory writing training program will offer attendees an understanding of the role of the regulatory writer in developing documentation for products in research, development, and in the marketplace. This session will highlight the mandates for documentation set forth by the regulators, such as the FDA, EMA, and other governing bodies. The program will train attendees on effectively writing, reviewing and revising documents.

Learning Objectives:

  • Understand the mandates for documentation set forth by the regulators such as the FDA, the EMA, and other governing bodies
  • Know how the reporting process supports products in research, development, and the marketplace
  • Understand requirements based on the phase of a clinical trial
  • Consider special regulatory categories such as orphan designations, accelerated approvals, and pediatric studies
  • Track a document’s path from initial correspondence, briefing books, clinical study protocols, amendments, clinical study reports, and complete technical documents
  • Describe the role of other clinical trial team members and learn strategies for effectively navigating the review process

Irene McKnight
Senior Medical Writer, Research & Development
CSL Behring


DAY 1

Thursday, October 25th, 2018

8:00 AM – 9:00 AM

REGISTRATION & BREAKFAST


9:00 AM – 9:15 AM

CHAIRPERSON’S OPENING REMARKS

Kirk Shepard
Senior Vice President, Head of Global Medical Affairs Oncology
Eisai Pharmaceutical


9:15 AM – 10:00 AM

BRING TOGETHER INTERNAL FUNCTIONS TO ELIMINATE SILOS AND CONSTRUCT A STRATEGY THAT IS IN THE BEST INTERESTS OF THE PATIENT

  • Recognize best practices for creating a collaborative team across departments
  • Sharing information and insights back and forth across functions
  • Identify how to effectively communicate as one team a comprehensive story that provides evidence for how and when to use treatments with patients

Jacob Runyan
Director, Scientific Communications
Boehringer Ingelheim


10:00 AM – 10:45 AM

PRIORITIZING MEDICAL COMMUNICATIONS WITH A STABLE SCIENTIFIC PLATFORM

  • Learn how organizations work together to approve essential medical communication activities 
  • Define clear goals within your team to ensure the everyone is aligned moving toward delivery
  • Discuss the review process of literature with experts 

Mindy Yang, Pharm.D.
Senior Director, Publications
Medical Affairs
Amicus Therapeutics


10:45 AM – 11:15 AM

NETWORKING BREAK


11:15 AM – 12:00 PM

ADDRESS IMPORTANCE OF COMMUNICATION AND COLLABORATION BETWEEN HOME MEDICAL AND FIELD MEDICAL TEAMS

  • Identify key ways in which home medical and field medical teams can effectively partner
  • Create strategies to increase flexibility
  • Describe the best approach to utilizing field insights to supplement overall medical and
    corporate strategy

Susan Shaffer
Head of Respiratory Global Medical Capabilities, Global Medical Affairs
AstraZeneca


12:00 PM – 1:00 PM

NETWORKING LUNCH


1:00 PM – 2:00 PM

ROUNDTABLE SESSIONS:

ROUNDTABLE ONE: MEDICAL INFORMATION

  • Develop solutions to manage support across the product lifecycle
  • Develop impactful solution and tips to improve customer service
  • Apply practical examples to enable more efficient use of existing resources

Lucy Hodge
Senior Manager, Global Medical Information
BioMarin Pharmaceuticals

ROUNDTABLE TWO: MEDICAL WRITING

  • Discuss how communication in publications has changed in a digital world
  • Review how your peers are partnering with outsourced writers 
  • Establish project management approaches used for top team communication 
  • Discuss how to navigate a changing regulatory landscape

Darryl Z. L'Heureux
Global Development and Medical Affairs, Medical Data Operations, MW Manager
Bristol-Myers Squibb

ROUNDTABLE THREE: MEDICAL SCIENCE LIAISONS

  • Evaluating the Value of the MSL Team to the Organization
  • How to maintain MSL authenticity under commercial pressures
  • Review the benefits and risks of disruptive forces within the current pharmaceutical environment
  • Detect how the future of the MSL role will be positively affected
  • Discuss how KPIs and metrics differ based on MSL support across the product lifecycle and on the size and longevity of an MSL program
  • Discuss how to collate the overall value message for MSLs that can be shared with key stakeholders

Kasmin (Boswell) Delgado
Senior MSL
Perrigo Pharmaceuticals


2:00 PM – 2:45 PM

Real World Evidence: Implications and Challenges for Medical Product Communications in an Evolving Regulatory Landscape

A confluence of factors is increasing and accelerating the digitization of large amounts of real world data generated on individuals and patients. Life science companies are looking to use RWD to gain various insights and how to measure and communicate the value of medical interventions and medicines. However, even with the increased use of data, regulators and policy-makers have struggled to define appropriate boundaries for its use in external communications, while supporting innovation. Thus, those in the pharmaceutical and medical device industries find themselves with an abundance of data, but with unanswered questions about how it can be properly communicated. RWD, describe some of its potential uses, and identify regulatory challenges on its use

  • How RWD data might be used in medical product communications to different audiences
  • Identify potential challenges that need to be addressed so that these data can more fully be utilized in responsible ways
  • Recent guidance from FDA on payer communications and communications consistent with label
  • Best practices for review and approval of RWD for use in promotion

Keren Tenenbaum
Assistant General Counsel
Pfizer


2:45 PM – 3:30 PM

DELIVERING VALUE BY MODERNIZING MEDICAL INFORMATION ENGAGEMENT STRATEGIES

  • Incorporate technology and digital strategies to empower clinical and formulary decision making
  • Discuss importance medical information omni-channel content strategies
  • Discuss importance of accessibility, timeliness of response, and tailoring content by customer types

Div Khetia, PharmD, MBA
Group Director, U.S. Medical Information Head
GSK


3:30 PM – 4:00 PM

NETWORKING & REFRESHMENT BREAK


4:00 PM – 4:30 PM

ENABLING VALUE DRIVEN PATIENT OUTCOMES: THE VALUE OF EARLY ENGAGEMENT OF MEDICAL AFFAIRS BOTH INTERNALLY WITHIN THE ORGANIZATION AND EXTERNALLY WITH OUR STAKEHOLDERS FOR SUCCESSFUL PRODUCT LAUNCHES

  • How Medical Affairs can shape the product and prepare the market for a successful product launches
  • Crucial activities that Medical Affairs functions undertake during pre-launch
  • Medical insights and how they inform early and long-term brand strategy
  • Importance of an integrated evidence generation plan that includes RWE strategies

Safura Babu-Khan
Medical Affairs Strategy Consultant and Former Head of Medical Launch Excellence, Shire Plc
Shire Plc


4:30 PM – 5:30 PM

PANEL: BEST PRACTICES FOR COLLABORATING WITH AUTHOR GROUPS

This panel discussion will examine tangible recommendations for achieving greater transparency and promoting practices that protect the integrity of authorship and how to best resolve authorship disputes that arise in the development of publications and product messages

Ann L. Davis, MPH, CMPP
Manager, Global Scientific and Medical Communications
Medical Development and Scientific/Clinical Affairs
Pfizer

Jim Gurr, PhD
Sr Manager, Global Scientific Communications
Publications Lead - Nusinersen
Biogen

Eric Wong
Director, Medical Communications
Janssen Therapeutics


5:30 PM – 5:45 PM

DAY ONE CLOSING REMARKS

Kirk Shepard
Senior Vice President, Head of Global Medical Affairs Oncology
Eisai Pharmaceutical


DAY 2

Friday, October 26th, 2018

8:00 AM – 9:00 AM

BREAKFAST


9:00 AM – 9:15 AM

CHAIRPERSONS RECAP OF DAY ONE

Kirk Shepard
Senior Vice President, Head of Global Medical Affairs Oncology
Eisai Pharmaceutical

 


9:15 AM – 10:00 AM

DISCUSS HOW THE ROLE OF MEDICAL COMMUNICATION HAS EVOLVED

  • Understand some of the factors that have influenced the way in which the biopharmaceutical industry and medical communications companies operate.
  • What changes can we expect and what can medical communications teams do to be prepared?
  • Challenges and opportunities for medical communications

Mina Patel
Senior Director, Global Scientific Communications
Alexion Pharmaceuticals Inc.


10:00 AM – 10:30 AM

UTILIZE REAL-WORLD EVIDENCE TO HELP CLINICIANS UNDERSTAND AND NAVIGATE ITS IMPLICATIONS

  • Enhance optimal treatment to patients by clearly demonstrating value to practitioners, payers, and providers
  • Accelerate coordination and integration of different health outcomes data and achieve external recognition for providing credible scientific information
  • Assess and provide real-world insights on patient journey and clarify opportunities for improving patient outcomes
  • Integrate components of a broader communication plan where a story of safety, value, efficacy, and effectiveness is delivered to support product use and access

Jamie Partridge, PhD, MBA
Director, Global Scientific Affairs, External Scientific Engagement, Health Economics Outcomes Research, Public Health & Policy
Abbott Nutrition


10:30 AM – 11:00 AM

NETWORKING & REFRESHMENT BREAK


11:00 AM – 11:45 AM

DISCOVER EMERGING TECHNOLOGIES TO SUPPORT MEDICAL COMMUNICATIONS

  • Discuss in what way AI and predictive models are being used to calculate the community impact of a given medical strategy
  • Discover how data is being used to create an informed and well position scientific platform and how AI can be used to predict the outcome of your products scientific platform
  • Learn how these new technologies are being used to improve publication strategy, conference strategy, opinion leader and influencer strategy

Jason Bradt
Executive Medical Director, Oncology, Americas Medical Affairs
Astellas Pharma


11:45 AM – 12:15 PM

HOW TO ENSURE QUALITY MEDICAL INFORMATION RESPONSES GLOBALLY

  • Identify and compare different technology solutions to develop and share content globally
  • Explain how to manage staff and key stakeholders through change
  • Define the importance of developing a MI content strategy and identify the resources necessary to deliver

Lucy Hodge
Senior Manager, Global Medical Information
BioMarin


12:15 PM – 1:15 PM

NETWORKING LUNCH


1:15 PM – 2:30 PM

MEDICAL AFFAIRS: A GROWING CAREER PATH – HOW TO MOVE FORWARD

With job functions within Medical Affairs constantly evolving, it can be difficult and often overwhelming to move forward to a new position. To help understand jobs and functions that often occur within medical affairs, join our panel of executives that chose different career paths. Hear how they each ended up in their current role and how you could advance in your own career.

Stanislav Glezer
VP, Global Medical Affairs, Diabetes Care 
Becton Dickinson

Lai H Jen, MD
Executive Director, Global Medical Information Physician – Oncology, Global Medical Affairs, Global Medical Information
Merck

Renu Juneja
Head, Scientific Communications and Training, Oncology Medical Affairs
Janssen Pharmaceuticals

Mina Patel
Senior Director, Global Scientific Communications
Alexion Pharmaceutical 


2:30 PM – 3:15 PM

DISCUSS CHALLENGES MEDICAL COMMUNICATIONS PROFESSIONALS FACE WITH REGULATORY COMPLIANCE 

  • How collaboration between medical affairs and compliance professionals ensures companies drive medical communications toward a new future
  • Understand the relevant regulatory and enforcement framework
  • Describe how to mitigate risk in medical communications

Karen Mittleman
Member of Board of Trustees and Global Transparency Committee
ISMPP

REFRESHMENTS SERVED IN BACK OF ROOM


3:15 PM – 3:30 PM

CHAIRPERSONS CLOSING REMARKS

Kirk Shepard
Senior Vice President, Head of Global Medical Affairs Oncology
Eisai Pharmaceutical

 


Download the Full Agenda

THREE DAYS OF EDUCATION AND INSIGHT

DON'T MISS IT

REGISTER NOW

FEATURING

Speakers & Faculty

Jake Runyan

Jake Runyan

Director, Scientific Communications
Boehringer Ingelheim

Mindy Yang

Mindy Yang

Senior Director, Publications, Medical Affairs
Amicus Therapeutics

Div Khetia

Div Khetia

Group Director, US Medical Information Head
GSK

Renu Juneja

Renu Juneja

Head, Scientific Communications and Training, Oncology Medical Affairs
Janssen Pharmaceuticals

Ann Davis

Ann Davis

Manager, Global Scientific and Medical Communications, Medical Development and Scientific/Clinical Affairs
Pfizer

Eric Wong

Eric Wong

Director, Medical Communications
Janssen Therapeutics

Jason Bradt

Jason Bradt

Executive Medical Director, Oncology, Americas Medical Affairs
Astellas Pharma

Kirk Shepard

Kirk Shepard

Senior Vice President, Head of Global Medical Affairs Oncology
Eisai Pharmaceutical Co.

J. Lynn Bass

J. Lynn Bass

Director, MSLs (Americas)
Santen, Inc.

Darryl Z. L’Heureux

Darryl Z. L’Heureux

Global Development and Medical Affairs, Medical Data Operations, MW Manager
Bristol-Myers Squibb

Mina Patel

Mina Patel

Senior Director, Global Scientific Communications
Alexion Pharmaceuticals Inc.

Jim Gurr

Jim Gurr

Sr. Manager, Global Scientific Communications
Biogen

Lucy Hodge

Lucy Hodge

Senior Manager, Global Medical Information
BioMarin Pharmaceutical

Stanislav Glezer

Stanislav Glezer

Chief Medical Officer
ADOCIA

Lai Jen

Lai Jen

Executive Director, Global Medical Information Physician – Oncology, Global Medical Affairs, Global Medical Information
Merck

Jamie Partridge

Jamie Partridge

Director, Global Scientific Affairs
Abbott Nutrition

Karen Mittleman

Karen Mittleman

Board Member
Intl. Society of Medical Publication Professionals

Irene McKnight

Irene McKnight

Senior Medical Writer, Research & Development
CSL Behring

Keren Tenenbaum

Keren Tenenbaum

Assistant General Counsel
Pfizer

Kasmin Delgado

Kasmin Delgado

Senior MSL
Perrigo Pharmaceuticals

Susan Shaffer

Susan Shaffer

Head of Respiratory Global Medical Capabilities, Global Medical Affairs
AstraZeneca

 
Safura Babu-Khan

Safura Babu-Khan

Medical Affairs Strategy Consultant and Former Head of Medical Launch Excellence
Shire Plc

 

REGISTRATION PRICING


CONFERENCE ONLY

STANDARD

$1,696

ON-SITE

$1,896

CONFERENCE + WORKSHOP

ONE-DAY WORKSHOP

(Register by October 24, 2018)

$996

STANDARD

$2,496

ON-SITE

$2,696

Register 2 Attendees, Get 1 Complimentary Registration!*

Interested in sending groups of 7 or more? Contact us directly for pricing.

*Excludes Workshop Only

EVENT SPONSORS

SPONSOR THIS EVENT

Contact Eric Morrin at (561) 221.6204
or email emorrin@dgeve.com

Exhibit Booth Package Sponsorship

$9,500

SPONSOR

Advertising Package Sponsorship

$6,500

SPONSOR